Delaware | ||||
(State or other jurisdiction of incorporation or organization) |
0-22705 (Commission File Number) |
33-0525145 (IRS Employer Identification No.) |
12790 El Camino Real | 92130 | |
(Address of principal executive offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events | ||||||||
Item 9.01 Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT 99.1 |
Dated: September 5, 2006 | NEUROCRINE BIOSCIENCES, INC. |
|||
/s/ MARGARET E. VALEUR-JENSEN | ||||
Margaret E. Valeur-Jensen | ||||
Executive Vice President, General Counsel and Corporate Secretary |
||||